Blood Genome-Wide Transcriptional Profiles of HER2 Negative Breast Cancers Patients

Figure 5

The network of TREM1 and PTGS2 (COX-2) upstream regulators and their target molecules, evaluated in the peripheral blood cells of breast cancer patients compared with healthy donors (Ingenuity Pathway Analysis).